Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Cisplatin with Radiochemotherapy for Inoperable Esophageal Cancer
NCT00238407Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Mar 2004
- Primary completion
- Feb 2008
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, Cisplatin micelle injection (HA132) in esophageal cancer, sponsored by Swiss Group for Clinical Cancer Research. Started Mar 2004; status: completed.
02
Drugs
docetaxelCisplatin micelle injection (HA132)
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00238407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238407.